Yale Cancer Center | VuMedi

Yale Cancer Center

Yale Cancer Center

https://www.yalecancercenter.org/

Lung

Yale Cancer Center

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity, Patient Selection, and How to Choose Between Available Agents

FEATURING Amin Nassar

177 views
August 22, 2023
1

ecancer

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of Adjuvant Osimertinib in Patients With Resected EGFRm Stage IB–IIIA NSCLC"

FEATURING Roy Herbst

397 views
June 14, 2023
3

Yale Cancer Center

Consolidation IO Following CRT in Stage III NSCLC

FEATURING Henry Park

221 views
March 17, 2023
2

Yale Cancer Center

Advancements in NSCLC: Multidisciplinary Case Panel Discussion

FEATURING Steven Benaderet, Michael Cohenuram, Sarah Goldberg, Vincent Mase Jr, Daniel Rudolph

236 views
November 30, 2022
1

Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening

FEATURING Justin Blasberg

186 views
August 23, 2022
1

Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening: Nurse Perspective

FEATURING Emily Kopas

75 views
August 23, 2022
1

i3 Health

2021 ES-SCLC Updates: Enhancing the Clinical Outcomes With Novel Therapeutic Strategies

FEATURING Anne Chiang

66 views
July 22, 2021

Yale Cancer Center

2020 Advances in Lung Cancer: What Are the Biggest NSCLC IO Advantages? What Are the 1L Options in Advanced Disease? Is Chemo Necessary? What Are the Available SCLC Options?

FEATURING Anne Chiang

41 views
December 9, 2020

Yale Cancer Center

Advances in Targeted Therapy for NSCLC: What Is the Importance of Biopsies in Identifying Acquired Resistance Mutations at Progression? How to Determine Who Will Benefit From Oral TKIs?

FEATURING Anne Chiang

260 views
December 8, 2020
1

Yale Cancer Center

ESMO 2019 Updated IMpower110 Trial Results: With Consistent OS/PFS Improvement, Atezolizumab Is a New 1st-Line Treatment Option for PD-L1-High Stage IV NSCLC

FEATURING Roy Herbst

1,729 views
January 7, 2020
9